Enable Accessibility Enable Accessibility

Director/PDMR Shareholding

April 2, 2013

Shire plc (LSE: SHP, NASDAQ: SHPG), (the “Company”) announces that on March 28, 2013 Ordinary Shares (“Shares”) and American Depository Shares (“ADSs”) of the Company, as set out below, had been acquired for the Non-Executive Directors, being the part of their total fees that are paid in shares for the period of service from January 1 to March 31, 2013.

  Type of Security(1) Number of Shares/ADSs
William Burns Shares 255
Dr. Steven Gillis ADSs 80
Dr. David Ginsburg ADSs 73
David Kappler Shares 302
Susan Kilsby ADSs 75
Anne Minto Shares 266
David Stout ADSs 81

(1) One ADS is equal to three Shares

The Shares and ADSs were acquired on the London Stock Exchange and NASDAQ respectively, at prices of £19.90 per Share and $90.00 per ADS.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

 

For further information please contact:

Investor Relations
Eric Rojas
erojas@shire.com
+1 781 482 0999

Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157

 

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:

  • Behavioral Health and Gastro Intestinal conditions
  • Rare Diseases
  • Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.

Click here for the PDF version of this press release.